About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Articles

The ‘Hack Attack’ Program: Enabling 24/7 Enrolment in the STEMI-DTU Pivotal Trial

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):22.

Wall Motion Score Index in Revascularisation and Ventricular Recovery

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):21.

Effect of Ventricular Unloading on Heart Recovery

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):20.

Complete Revascularisation and Acute Unloading Prior to Percutaneous Coronary Intervention Increases Survival in Acute MI Cardiogenic Shock

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):18–9.